|
|
Other links at Articles > Business of Medicine |
| 1. |
FDA Approves Toviaz for Overactive Bladder
|
|
|
By relaxing the bladder muscle, fesoterodine fumarate (Toviaz) reduces urinary frequency, the urge to urinate, and sudden urinary incontinence associated with OAB. Medscape Medical News
|
| 2. |
Post-Op Ileus Drug Safety Unclear: FDA Staff
|
|
|
A U.S. regulatory review of a drug to treat post-operative ileus (POI) found that the subsequent MI rate was similar to that seen with placebo, but the investigators said no conclusion could be drawn because of limited patient follow-up. Reuters Health Information
|
| 3. |
Heart-Imaging Agent Gets FDA Approval
|
|
|
Drug makers CV Therapeutics and Astellas Pharma Inc said on Friday the U.S. Food and Drug Administration (FDA) had approved their heart-imaging agent regadenoson, also called Lexiscan. Reuters Health Information
|
| 4. |
U.S. FDA Says Zila Mouth Rinse Promotion Misleading
|
|
|
The U.S. Food and Drug Administration has warned Zila Pharmaceuticals Inc about promoting its Peridex oral rinse without including information about possible risks, according to a letter released on Tuesday. Reuters Health Information
|
|
|
